Literature DB >> 33504779

Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics.

Monica C Pillon1,2, Meredith N Frazier3, Lucas B Dillard4, Jason G Williams5, Seda Kocaman3, Juno M Krahn4, Lalith Perera4, Cassandra K Hayne3, Jacob Gordon3,6,7,8, Zachary D Stewart3, Mack Sobhany3, Leesa J Deterding5, Allen L Hsu4, Venkata P Dandey4, Mario J Borgnia4, Robin E Stanley9.   

Abstract

Nsp15, a uridine specific endoribonuclease conserved across coronaviruses, processes viral RNA to evade detection by host defense systems. Crystal structures of Nsp15 from different coronaviruses have shown a common hexameric assembly, yet how the enzyme recognizes and processes RNA remains poorly understood. Here we report a series of cryo-EM reconstructions of SARS-CoV-2 Nsp15, in both apo and UTP-bound states. The cryo-EM reconstructions, combined with biochemistry, mass spectrometry, and molecular dynamics, expose molecular details of how critical active site residues recognize uridine and facilitate catalysis of the phosphodiester bond. Mass spectrometry revealed the accumulation of cyclic phosphate cleavage products, while analysis of the apo and UTP-bound datasets revealed conformational dynamics not observed by crystal structures that are likely important to facilitate substrate recognition and regulate nuclease activity. Collectively, these findings advance understanding of how Nsp15 processes viral RNA and provide a structural framework for the development of new therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33504779      PMCID: PMC7840905          DOI: 10.1038/s41467-020-20608-z

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  42 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  Biochemical characterization of arterivirus nonstructural protein 11 reveals the nidovirus-wide conservation of a replicative endoribonuclease.

Authors:  Danny D Nedialkova; Rachel Ulferts; Erwin van den Born; Chris Lauber; Alexander E Gorbalenya; John Ziebuhr; Eric J Snijder
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

3.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy.

Authors:  Shawn Q Zheng; Eugene Palovcak; Jean-Paul Armache; Kliment A Verba; Yifan Cheng; David A Agard
Journal:  Nat Methods       Date:  2017-02-27       Impact factor: 28.547

4.  Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography.

Authors:  D D Leonidas; G B Chavali; A M Jardine; S Li; R Shapiro; K R Acharya
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

5.  The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor.

Authors:  Kanchan Bhardwaj; Linda Guarino; C Cheng Kao
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.

Authors:  Demetres D Leonidas; Gayatri B Chavali; Nikos G Oikonomakos; Evangelia D Chrysina; Magda N Kosmopoulou; Metaxia Vlassi; Claire Frankling; K Ravi Acharya
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

7.  It takes two (Las1 HEPN endoribonuclease domains) to cut RNA correctly.

Authors:  Monica C Pillon; Kevin H Goslen; Jacob Gordon; Melissa L Wells; Jason G Williams; Robin E Stanley
Journal:  J Biol Chem       Date:  2020-03-27       Impact factor: 5.157

8.  Presenting your structures: the CCP4mg molecular-graphics software.

Authors:  S McNicholas; E Potterton; K S Wilson; M E M Noble
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

Review 9.  An "Old" protein with a new story: Coronavirus endoribonuclease is important for evading host antiviral defenses.

Authors:  Xufang Deng; Susan C Baker
Journal:  Virology       Date:  2018-01-04       Impact factor: 3.616

10.  Insight into the evolution of nidovirus endoribonuclease based on the finding that nsp15 from porcine Deltacoronavirus functions as a dimer.

Authors:  Anjun Zheng; Yuejun Shi; Zhou Shen; Gang Wang; Jiale Shi; Qiqi Xiong; Liurong Fang; Shaobo Xiao; Zhen F Fu; Guiqing Peng
Journal:  J Biol Chem       Date:  2018-06-10       Impact factor: 5.157

View more
  22 in total

1.  Flipped over U: structural basis for dsRNA cleavage by the SARS-CoV-2 endoribonuclease.

Authors:  Meredith N Frazier; Isha M Wilson; Juno M Krahn; Kevin John Butay; Lucas B Dillard; Mario J Borgnia; Robin E Stanley
Journal:  Nucleic Acids Res       Date:  2022-08-12       Impact factor: 19.160

2.  Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis.

Authors:  Ibrahim M Ibrahim; Abdo A Elfiky; Mohamed M Fathy; Sara H Mahmoud; Mahmoud ElHefnawi
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

Review 3.  Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs.

Authors:  Neda Eskandarzade; Abozar Ghorbani; Samira Samarfard; Jose Diaz; Pietro H Guzzi; Niloofar Fariborzi; Ahmad Tahmasebi; Keramatollah Izadpanah
Journal:  Comput Biol Med       Date:  2022-04-30       Impact factor: 6.698

Review 4.  Recent insights into the structure, function, and regulation of the eukaryotic transfer RNA splicing endonuclease complex.

Authors:  Cassandra K Hayne; Tanae A Lewis; Robin E Stanley
Journal:  Wiley Interdiscip Rev RNA       Date:  2022-02-14       Impact factor: 9.349

5.  A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations.

Authors:  Sumit Kumar; Yash Gupta; Samantha E Zak; Charu Upadhyay; Neha Sharma; Andrew S Herbert; Ravi Durvasula; Vladimir Potemkin; John M Dye; Prakasha Kempaiah; Brijesh Rathi
Journal:  RSC Med Chem       Date:  2021-08-18

Review 6.  Structural biology of SARS-CoV-2: open the door for novel therapies.

Authors:  Weizhu Yan; Yanhui Zheng; Xiaotao Zeng; Bin He; Wei Cheng
Journal:  Signal Transduct Target Ther       Date:  2022-01-27

Review 7.  A structural view of the SARS-CoV-2 virus and its assembly.

Authors:  Nathan J Hardenbrook; Peijun Zhang
Journal:  Curr Opin Virol       Date:  2021-12-04       Impact factor: 7.121

8.  The severe acute respiratory syndrome coronavirus 2 non-structural proteins 1 and 15 proteins mediate antiviral immune evasion.

Authors:  Nitish Boodhoo; Ayumi Matsuyama-Kato; Bahram Shojadoost; Shahriar Behboudi; Shayan Sharif
Journal:  Curr Res Virol Sci       Date:  2022-02-12

9.  Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.

Authors:  Berta Canal; Ryo Fujisawa; Allison W McClure; Tom D Deegan; Mary Wu; Rachel Ulferts; Florian Weissmann; Lucy S Drury; Agustina P Bertolin; Jingkun Zeng; Rupert Beale; Michael Howell; Karim Labib; John F X Diffley
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

10.  Predicted antiviral drugs Darunavir, Amprenavir, Rimantadine and Saquinavir can potentially bind to neutralize SARS-CoV-2 conserved proteins.

Authors:  Umesh C Halder
Journal:  J Biol Res (Thessalon)       Date:  2021-08-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.